Work

HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival

Year: 2020

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2020.08.023

Authors: Anastasios Dimou, Paul Grewe, John Sidney, Alessandro Sette, Paul J. Norman, Robert C. Doebele

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), University of Colorado Anschutz, University of Colorado Denver, La Jolla Institute for Immunology, University of California San Diego

Language: English

Topic: vaccines and immunoinformatics approaches

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Association for Cancer Research, Conquer Cancer Foundation, LAM Therapeutics, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G4112664186, Development of a pipeline tool to predict immunogenicity of cancer neo-epitopes, G46869954, SPORE in Lung Cancer, Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data, Insights Into Immune-Related Diseases Born from Population Genomics

OpenAlex ID: W3086482022

FWCI: 0.324

Cites: 36

Cited by: 11

Related to: 10